Preventing anemia is important to kidney disease patients' quality of lifeNovember 12, 2008Study indicates that FDA statements may need to be revised Maintaining sufficient red blood cell levels is important to the physical and mental health of patients with chronic kidney disease (CKD), according to a study appearing in the January 2009 issue of the Clinical Journal of the American Society Nephrology (CJASN). The findings indicate that preventing anemia in kidney disease patients should be an integral part of their care. Erythropoiesis-stimulating agents-medications that elevate red blood cell levels (hemoglobin)-have been a topic of controversy lately, and their use in patients with chronic kidney disease has come into question. Recent studies have shown an increased risk of death, blood clots, strokes, and heart attacks in patients with chronic kidney failure when erythropoiesis-stimulating agents are given at higher than recommended doses. (Current recommendations indicate that treatment should not elevate hemoglobin levels over 12 gm/dl). Other studies have found a link between the recommended doses of these drugs and an increased risk of death in patients with cancer and an increased risk of blood clots in patients following orthopedic surgery. In addition, the US Food and Drug Administration stated that the benefits of erythropoiesis-stimulating agents have not been well documented, particularly as they relate to quality of life. These suggestions are disturbing to nephrologists, who believe that these drugs have significantly helped their CKD patients.
To help clarify the issue, Fredric Finkelstein, MD, of the Hospital of St. Raphael and Yale University in New Haven, CT, and his colleagues studied the relationship between hemoglobin levels and health-related quality of life (which includes both mental and physical components) in patients with CKD. A total of 1,186 patients with stage three to stage five CKD participated in this study, and they were grouped into categories based on their hemoglobin levels (<11 gm/dl, 11 to <12 gm/dl, 12 to <13 gm/dl, and ≥13 gm/dl). The investigators noted that as hemoglobin levels increased from <11 gm/dl to ≥13 gm/dl, there were significant improvements in a variety of quality of life domains. These included symptom problems, burden of kidney disease, physical functioning, pain, energy/fatigue, and others. The study's findings suggest that maintaining hemoglobin levels is important to the health and well-being of patients with CKD. The authors recommend that additional studies should be done to document the changes in quality of life that occur when erythropoiesis-stimulating agents are used to elevate hemoglobin levels in patients with this disease. More work also is needed to determine when treatment should be initiated and what the hemoglobin target level should be. "The impact of the answers to these questions for the health-related quality of life of chronic kidney disease patients may well be substantial," the authors wrote. American Society of Nephrology Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Climate Change Alcohol Use Loneliness Antiretroviral Cyanobacteria Aphids Fuel Cells Milk Vaccine Development Ovarian Tissue Kawasaki Disease Pancreatic Cancer Coral Reefs Metastasis Quality Of Life Glycemic Index Enzyme Visual Cortex Metabolism Technology Facial Expressions Selenium Weight Gain Motor Neurons Genomes
See More: Science News Tags | |||||||||||||||||||||
|
Related Kidney Disease Current Events and Kidney Disease News Articles U finds treatment that significantly slows progression of eye damage in persons with type 1 diabetes University of Minnesota Medical School researcher Michael Mauer, M.D., has found a treatment that significantly slows the progression of eye injury in people with type 1 diabetes, a common complication caused by this disease. Even at High Doses, Gadolinium-Based Contrast Agents Cannot by Themselves Cause Patients to Develop Nephrogenic Systemic Fibrosis Even at very high doses, gadolinium-based contrast agents alone are not sufficient to cause nephrogenic systemic fibrosis (NSF) in patients with kidney problems. Structures from the human immune system's oldest branch shed light on a range of diseases How molecules of the oldest branch of the human immune system have interconnected has remained a mystery. Natural hormone offers hope for treatment of the metabolic syndrome Angiotensin 1-7, a hormone in the body that has cardiovascular benefits, improves the metabolic syndrome in rats, according to a new study. The results will be presented Wednesday at The Endocrine Society's 91st Annual Meeting in Washington, D.C. A first choice of renal function tests in hepatectomy patients Although creatinine clearance (Ccr) has been measured clinically by a simple method as a preoperative renal function test, Ccr is not strictly equal to glomerular filtration rate (GFR). Study indicates that a common virus could cause high blood pressure A new study suggests for the first time that cytomegalovirus (CMV), a common viral infection affecting between 60 and 99 percent of adults worldwide, is a cause of high blood pressure, a leading risk factor for heart disease, stroke and kidney disease. Scripps research scientists discover molecular defect involved in hearing loss Scientists from The Scripps Research Institute have elucidated the action of a protein, harmonin, which is involved in the mechanics of hearing. System that regulates blood pressure is amiss in some healthy, young blacks When stress increases blood pressure, a natural mechanism designed to bring it down by excreting more salt in the urine doesn't work well in about one-third of healthy, black adolescents, researchers report. Study finds novel genetic risk factors for kidney disease A team of researchers from the United States, the Netherlands and Iceland has identified three genes containing common mutations that are associated with altered kidney disease risk. Elevated level of certain protein in urine linked to increased risk for blood clots Preliminary research suggests that higher than normal levels of the protein albumin in urine is associated with an increased risk for blood clots in the deep veins of the legs or lungs (venous thromboembolism; VTE), according to a study in the May 6 issue of JAMA. More Kidney Disease Current Events and Kidney Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||